Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Alembic Pharma rises on getting USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

14-Sep2018

Alembic Pharma rises on getting USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

Alembic Pharmaceuticals is currently trading at Rs. 647.10, up by 6.90 points or 1.08% from its previous closing of Rs. 640.20 on the BSE.

The scrip opened at Rs. 641.00 and has touched a high and low of Rs. 652.00 and Rs. 637.50 respectively. So far 7567 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 657.00 on 12-Sep-2018 and a 52 week low of Rs. 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs. 657.00 and Rs. 597.55 respectively. The current market cap of the company is Rs. 12144.20 crore.

The promoters holding in the company stood at 72.96%, while Institutions and Non-Institutions held 14.30% and 12.74% respectively.

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), KAZANO Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg of Takeda Pharma USA. Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg are indicated as an adjunct to diet and exercise to improve giycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and metformin is appropriate.

Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg has an estimated market size of $22.5 million for twelve months ending December 2017 according to IQVIA. Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Related News

View all news

Mindtree rises on crossing $1 billion in annual revenue

Mindtree is currently trading at Rs. 983.85, up by 11.70 points or 1.20% from its previous closing of Rs. 972.15 on the BSE.The scrip opened at Rs. 977.00 and has touched a high and low of Rs. 986.45 and......

INDSIL Hydro Power trades in green on the bourses

Indsil Hydro Power and Manganese is currently trading at Rs. 60.00, up by 0.35 points or 0.59% from its previous closing of Rs. 59.65 on the BSE.The scrip opened at Rs. 60.40 and has touched a high and......

SpiceJet flies high on the bourses

Spicejet is currently trading at Rs. 142.10, up by 9.40 points or 7.08 % from its previous closing of Rs. 132.70 on the BSE.The scrip opened at Rs. 144.00 and has touched a high and low of Rs. 152.60 and......

Top News

View all news

Quess Corp, Ashoka Buildcon and ICICI Bank to see some action today

Quess Corp's subsidiary Conneqt Business Solutions has signed definitive agreements to acquire a majority stake in Allsec Technologies. The transaction involves Conneqt purchasing 35.35% from the promoters,......

Quess Corp's arm to acquire majority stake in Allsec Technologies

Quess Corp's subsidiary -- Conneqt Business Solutions has signed definitive agreements to acquire a majority stake in Allsec Technologies. The transaction involves Conneqt purchasing 35.35% from the promoters,......

Ashoka Buildcon's JV receives LoA from Rail Vikas Nigam

Ashoka Buildcon's Joint Venture (JV) -- ABL-STS JV, wherein the Company is lead member, has received a Letter of Award (LoA) from Rail Vikas Nigam (RVNL). The accepted Bid Value of the Project is Rs 443.23......